Native Pulmonic Valve Endocarditis due to Mycobacterium fortuitum: A Case Report and Literature Review

Table 1

Reported cases of native valve endocarditis caused by Mycobacterium fortuitum.

Reference	Age	Gender	Valves affected	Associated procedures	Comorbidities	Organism isolated from other sources	Surgical therapy	Antibiotic therapy	Survival
Our patient (2015)	64	Female	Pulmonic	None	End-stage COPD, bioprosthetic MVR, mitral stenosis	Tracheal aspirate, PICC	No	Amikacin, imipenem, clarithromycin	No
Vuković et al. [7]	12	Female	Tricuspid	Bovine patch VSD repair	None	No	No	Not reported	Alive at 12 months after diagnosis
	2	Female	Tricuspid	Bovine patch VSD repair	Down syndrome	No	No	Not reported	Alive at 12 months after diagnosis
	0.5	Male	Tricuspid	Bovine patch VSD repair	None	Vegetation, VSD patch	VSD patch removal,; VSD repair	Not reported	Alive at 12 months after diagnosis
Natsag et al. [8]	49	Female	Aortic, tricuspid	IVDU	Skin abscesses, hepatitis C	No	No	TMP/SMX, linezolid, ciprofloxacin	Alive at 6 weeks after diagnosis
Collison and Trehan [9]	50	Male	Mitral, aortic	PCI and stent placement	Coronary artery disease, congestive heart failure	Not reported	AVR, MVR, coronary artery bypass graft	Clarithromycin, imipenem, moxifloxacin, amikacin	No
Singh et al. [10]	54	Female	Aortic	Hemodialysis	Aortic stenosis, mitral regurgitation, ESRD	No	No	TMP/SMX, ciprofloxacin, amikacin, clofazimine	No
Spell et al. [11]	47	Male	Aortic	IVDU	Human immunodeficiency virus	No	AVR offered (patient declined)	Amikacin, ciprofloxacin, cefoxitin	No
Kuruvila et al. [12]	20	Female	Mitral	Balloon mitral valvulotomy	Rheumatic heart disease	Cerebrospinal fluid	No	Amikacin, azithromycin, rifampin	No

VSD: ventricular septal defect; PCI: percutaneous coronary intervention; IVDU: intravenous drug use; COPD: chronic obstructive pulmonary disease; ESRD: end-stage renal disease; PICC: peripherally inserted central catheter; MVR: mitral valve replacement.